Health Spending and First Quarter GDP: What the Heck Happened?
Forbes: ObamaCare is increasing uncertainty and government control which dampens economic growth, says NCPA Senior Fellow John R. Graham in a Forbes commentary.
Go Economy Go! U.S. Jobs Report is Strong for the Right Reasons
Forbes: The July job report shows signs of improving for the “right reasons,” says NCPA Distinguished Fellow Bob McTeer in a Forbes commentary.
The President’s Minimum Wage Proposal
Forbes: Denying the negative consequences of raising the minimum wage leaves supporters of the proposal vulnerable to “reduction ad absurdum,” says NCPA Distinguished Fellow Bob McTeer in a Forbes commentary.
India's Lack of Intellectual Property Protection Hurting U.S. Companies
NCPA: India’s lack of intellectual property right enforcement strains the pharmaceutical trade relationship between India and the United States, explains Research Associate Clinton Ritchey in a new report from the National Center for Policy Analysis (NCPA).
Dennis McCuistion
Dennis McCuistion served as interim President and CEO of the National Center for Policy Analysis (NCPA) from June to December 2014. He as a corporate governance and strategic planning expert. …
India’s Weak Patent Rights Hurt U.S. Pharmaceutical Trade
India is one of the top global leaders in the generic pharmaceutical drug market. The third largest drug producer in the world, India is also the second largest exporter of generic drugs to the United States, behind only Canada. India’s success in pharmaceutical manufacturing prompted President Pratibha Patil to declare, in 2010, that the next 10 years will be India’s “decade of innovation.”